Coastal Investment Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$883.2 - $1071.19 $3,532 - $4,284	4 Added 1.5%	270 $283,000
Q1 2024 Apr 19, 2024	BUY	$902.69 - $993.35 $240,115 - $264,231	266 New	266 $256,000
Q1 2020 Apr 23, 2020	SELL	$336.18 - $494.43 $56,814 - $83,558	-169 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$299.6 - $414.82 $599 - $829	-2 Reduced 1.17%	169 $53,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $63,625 - $75,166	171 New	171 $71,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.